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Abstract
Background: Sorting nexins (SNXs) constitute a family of proteins classified by their phosphatidylinositol (PI) binding Phox
homology (PX) domain. Some members regulate intracellular trafficking. We have here investigated mechanisms underlying
SNX4 mediated endosome to Golgi transport.
Methodology/Principal Findings: We show that SNX4 forms complexes with clathrin and dynein. The interactions were
inhibited by wortmannin, a PI3-kinase inhibitor, suggesting that they form when SNX4 is associated with PI(3)P on
endosomes. We further localized the clathrin interacting site on SNX4 to a clathrin box variant. A short peptide containing
this motif was sufficient to pull down both clathrin and dynein. Knockdown studies demonstrated that clathrin is not
required for the SNX4/dynein interaction. Moreover, clathrin knockdown led to increased Golgi transport of the toxin ricin,
as well as redistribution of endosomes.
Conclusions/Significance: We discuss the possibility of clathrin serving as a regulator of SNX4-dependent transport. Upon
clathrin release, dynein may bind SNX4 and mediate retrograde movement.
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Introduction
Sorting nexins (SNXs) constitute a group of proteins classified
by their phosphatidylinositol (PI) binding SNX-PX domain, a
subgroup of the PX (Phox homology) domain family. Several of
the SNXs have been shown to play a role in intracellular transport.
For instance, SNX1 and SNX2 have been suggested to be part of
the mammalian retromer [1–5], a coat complex involved in
endosome to Golgi transport [6]. A few years ago, it was reported
that there must be at least one additional retrieval pathway [7],
and it was later shown that SNX4/41/42 mediate such a pathway
in yeast [8]. SNX4 has also in mammalian cells been shown to
mediate endosome to Golgi transport by a pathway different from
SNX1 [9,10].
SNX4 has a PI(3)P binding PX domain, and has been reported
to localize to endosomes in an hVps34 dependent manner [9].
hVps34 is the PI3-kinase responsible for the production of most of
the PI(3)P on endosomes [11]. In agreement with this, SNX4 is an
effector of the hVps34 dependent endosome to Golgi transport
pathway used by ricin [9]. This protein toxin is after endocytosis
transported via early endosomes to the Golgi apparatus, and
further to the endoplasmic reticulum (ER). From this compart-
ment, it enters the cytosol where it exerts its toxic effect [12]. The
role of hVps34 in ricin retrograde transport is in agreement with
the suggestion that hVps34 activity may be required for minus-
end-directed movement of endosomes along microtubuli [13].
This is further supported by the recent report showing that SNX4
is involved in endosomal sorting of the transferrin receptor via an
indirect association with the minus end-directed microtubule
motor protein dynein [10].
In the present study, we have identified clathrin heavy chain
(CHC), tubulin and dynein as SNX4 interacting proteins. We have
studied how these proteins interact, and characterized a novel
clathrin box variant in SNX4. Upon CHC knockdown, Golgi
transport of ricin is enhanced. We discuss the possibility of CHC
serving as a regulator of SNX4-dependent transport. When CHC
is released, dynein may bind SNX4 and mediate retrograde
movement.
Materials and Methods
Reagents and antibodies
Ricin, wortmannin and nocodazole were from Sigma-Aldrich
(St. Louis, MO). Restriction enzymes were from New England
Biolabs (Ipswich, MA). Protein A Sepharose beads were purchased
from Amersham Biosciences (Buckinghamshire, UK). Antibodies
used in this study were anti-SNX4 (E-18; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA for WB and IP (2 mg per sample), and M01,
clone 4H8; Abnova, Taipei City, Taiwan for IF), anti-clathrin
heavy chain (CHC) (RDI Division of Fitzgerald Industries
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5935International, Concord, MA for WB, and Acris GmbH,
Hiddenhausen, Germany for IF), anti-c-tubulin and anti-a-tubulin
(Sigma-Aldrich), anti-dynein (IC74; Chemicon International,
Temecula, CA), anti-actin (Nordic Biosite, Ta ¨by, Sweden), anti-
EEA1 (a gift from Harald Stenmark [14]), anti-myc (9E10; Santa
Cruz Biotechnology), anti-ricin (Sigma-Aldrich), and anti-TGN46
(Serotec, Oxford, UK). HRP-conjugated secondary antibodies
were from Jacksom Immunoresearch (West Grove, PA) and
eBioscience (San Diego, CA).
Cell culture
Human Embryonic Kidney (HEK) 293 cells were grown under
5% CO2 in DMEM supplemented with 10% fetal calf serum
(FCS), 100 U/ml penicillin and 100 U/ml streptomycin (Invitro-
gen, Carlsbad, CA). The tissue culture plates were coated with
Poly-L-lysine (Sigma-Aldrich) according to the manufacturer’s
protocol.
Constructs, oligos and transfection
The wild-type SNX4 gene was a kind gift from Carol Haft
(National Institutes of Health, Bethesda, MD) [15], and was
amplified using the primers 59-GCTCTAGACTATTA-
CATCTTGCTAAAGCATTCCTT-39 and 59-TATAGATCT-
GAGCAGGCACCTCCGGAC-39, which added XbaI and BglII
restriction sites (underlined), respectively. The product was cloned
into pEGFP-C1 (Novagen, Madison, WI) using these enzymes,
resulting in GFP-SNX4. Full-length and mutant SNX4 with myc
and 66His tags were cloned using the primer 59-TATAAGCT-
TATGGAGCAGGCACCTCCGGAC-39 (both constructs),
which added a HindIII restriction site, and 59-ATACTCGAG-
CATCTTGCTAAAGCATTCCTT-39 (SNX4 wt) or 59-
ATACTCGAGCTGAAACCCAGTTTCATTCAC-39 (SNX4
198-451D), which added an XhoI restriction site. The product
was cloned into pcDNA4 (Invitrogen) using these enzymes. SNX4
109-113D was generated from the wild-type using site-directed
mutagenesis. All constructs were sequenced. GFP-CLC was a kind
gift from Joshua Z. Rappoport (School of Biosciences University of
Birmingham Edgbaston, Birmingham, UK) and James H. Keen
(Thomas Jefferson University, Philadelphia, PA). Cells were
transfected with the different constructs using Fugene 6 (Roche
Diagnostics, Mannheim, Germany) according to the manufactur-
er’s protocol.
To target clathrin heavy chain with siRNA, we used both vector
and oligo based siRNAs. The validated targeting sequence in the
vector was GCATGATGTGGTGTTCTTGAT (siCHCv) [16],
and for the oligos GCAATGAGCTGTTTGAAGA (siCHCo)
[17] and TAATCCAATTCGAAGACCAAT (siCHCo2) [18].
siRNAs against SNX4 were previously described [9]. Cells were
transiently transfected for 3–4 days with plasmid DNA using
Fugene 6 (Roche Diagnostics, Mannheim, Germany), or with
40 nM siRNA oligo for 3 days using Dharmafect 2 (Dharmacon,
Lafayette, CO), according to the manufacturer’s protocol. Control
cells were transfected with a mock vector or a negative control
oligo (Eurogentec, Seraing, Belgium), respectively.
Immunoprecipitation
Cells were treated as indicated in the figure legends before lysis
(lysis buffer: 0.1 M NaCl, 10 mM Na2HPO4 (pH 7.4), 1 mM
EDTA, 1% Triton X-100, supplemented with a mixture of
Complete protease inhibitors (Roche Diagnostics)). Cleared lysate
was immunoprecipitated with the appropriate antibody, prebound
to Protein A Sepharose beads, for the indicated time at 4uC. The
immunoprecipitate was washed at least twice with 0.35% Triton
X-100 in PBS and resuspended in sample buffer, subjected to
SDS-PAGE and transferred to a PVDF membrane. Immuno-
staining was performed with the indicated antibodies. Alterna-
tively, cells were lysed in the same lysis buffer containing 60 mM n-
octyl-b-glucopyranoside, obtaining the same results (not shown).
Confocal fluorescence microscopy
Cells were grown on glass coverslips and treated as indicated in
the figure legends. The cells were fixed with 4% formalin solution
(Sigma-Aldrich), permeabilized with 0.2% Triton X-100 in PBS
and immunostained with appropriate antibodies. Fluorophore-
labeled secondary antibodies were from Jackson Immunoresearch
(West Grove, PA). DRAQ5 (Alexis Biochemicals, San Diego, CA)
was used to stain the nuclei. The cells were mounted in Mowiol
(Calbiochem, San Diego, CA) and examined by the laser scanning
confocal microscope LSM 510 META (Carl Zeiss, Jena,
Germany). Images were prepared and analyzed with the LSM
Image Browser software (Carl Zeiss).
Sulfation assays
Cells transfected as indicated were washed twice with sulfate-
free medium (MEM 12–126, BIO Whittaker, Walkersville, MD)
before incubation with 0.2 mCi/ml Na2
35SO4 for 3 hours at 37uC
in the same medium. They were next incubated with ricin sulf-1
[19] for 90 minutes. The cells were then washed with ice-cold PBS
and lysed in lysis buffer (0.1 M NaCl, 10 mM Na2HPO4 (pH 7.4),
1 mM EDTA, 1% Triton X-100, supplemented with a mixture of
Complete protease inhibitors). Ricin was immunoprecipitated
from cleared lysate with anti-ricin antibodies. The immunopre-
cipitate was separated by SDS-PAGE and transferred to a
membrane for investigation by autoradiography. Band intensities
were quantified using ImageQuant 5.0 software (Molecular
Dynamics, Sunnyvale, CA). As an internal control, total protein
sulfation was measured after TCA-precipitation of the lysates, and
shown to remain similar to control levels (data not shown).
Mannosylation assays
Cells transfected as indicated were washed twice with glucose-
free medium (DMEM 11966, Invitrogen) before incubation with
0.2 mCi/ml D-[2-
3H(N)]-Mannose for 3 hours at 37uC in the
same medium. Ricin sulf-2 [19] was then added, and the
incubation continued for 3 hours. The cells were then washed
with ice-cold PBS and lysed in lysis buffer (0.1 M NaCl, 10 mM
Na2HPO4 (pH 7.4), 1 mM EDTA, 1% Triton X-100, supple-
mented with a mixture of Complete protease inhibitors). Ricin was
immunoprecipitated from cleared lysate with anti-ricin antibodies.
The immunoprecipitate was separated by SDS-PAGE and
transferred to a membrane for investigation by autoradiography.
Band intensities were quantified using ImageQuant 5.0 software
(Molecular Dynamics, Sunnyvale, CA). As an internal control,
total protein mannosylation was measured after TCA-precipita-
tion of the lysates.
GST protein purification and pull-down
Detailed description of construct cloning can be found in Text
S1 online. GST-Hrs707–775 was a gift from Harald Stenmark [20].
Competent bacteria transformed with the different constructs were
grown in 20 mL LB medium containing 50 mg/mL ampicillin at
37uC overnight. The next day, 180 mL LB/ampicillin was added,
and the bacteria grown at 37uC until OD600=0.5. At this point,
1 mM IPTG (Saveen Werner AB, Malmo ¨, Sweden) was added
and the bacteria induced for 3 h at 37uC. The bacteria were
pelleted by centrifugation at 4uC, and stored at 220uC until the
next day. The pellet was then resuspended in 5 mL GST-buffer
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complete protease inhibitors (Roche Diagnostics). The bacteria
were next sonicated for 5 min on ice at 30% output. Triton X-100
(Sigma-Aldrich) was added to 1% final concentration and the
lysate left for 30 min at 4uC with continuous rolling. A high-speed
centrifugation at 4uC was performed, and the cleared lysate
incubated with 100 ml Glutathione Sepharose beads (GE Health-
care, Uppsala, Sweden) in a sealed 10 mL disposable column (Bio-
Rad, Hercules, CA) for 2 h at 4uC with continuous rolling. The
lysate was then run through the column, and the beads washed
once with 5 mL of each buffer 1 (0.1 M Tris, pH 7.8, 0.5 M
NaCl), GST-buffer containing 0.35% Triton X-100 and GST-
buffer alone. The column was sealed and the slurry containing
GST-proteins resuspended in 100 ml GST-buffer supplemented
with protease inhibitors and stored at 4uC.
In pull-down experiments, a similar amount of the different
GST proteins were added to 20 ml Glutathione Sepharose beads
(used as carrier) and 200 ml HEK293 cell lysate complemented
with protease inhibitors. The mix was kept at 4uC overnight with
rolling. The beads were washed 2–3 times with 0.1% Triton X-
100 in PBS, and once with PBS alone. Reducing sample buffer
was added, and the samples boiled at 95uC for 5 min before
separation on SDS-PAGE and transfer to a PVDF membrane.
Western blot was performed with the indicated antibodies.
Results
SNX4 interacts with clathrin, tubulin and dynein
In order to identify endosomal binding partners of SNX4, we
performed co-immunoprecipitation experiments in the presence or
absence of wortmannin, a PI3-kinase inhibitor shown to relocalize
the PI(3)P binding SNX4 away from endosomes [9]. As shown in
Figure 1a, clathrin heavy chain (CHC) was identified in the SNX4
precipitate, but not in the negative control (- IgG). A complex
involving SNX4 and CHC has not previously been reported. Since
we were interested in understanding how SNX4-positive endo-
Figure 1. SNX4 co-immunoprecipitates CHC, tubulin and dynein. (a) HEK293 cells were treated with or without 100 nM wortmannin (Wort.)
for 30 min, or transfected with control or SNX4 siRNA for 72 h, before lysis and anti-SNX4 immunoprecipitation at 4uC overnight. As a negative
control, cell lysate was treated without antibody. The immunoprecipitate and whole cell lysate (WCL) were then separated by SDS-PAGE and analyzed
by Western blot with the indicated antibodies. (b) Cells were transfected with control or SNX4 siRNA for 72 h before fixation and staining with anti-
CHC antibodies. (c) Cells were treated with or without 100 nM wortmannin for 30 min before fixation and staining with anti-tubulin antibodies. (d)
Cells were treated with or without 20 mM nocodazole for 30 min before fixation and antibody staining. DRAQ5 was used to stain the nuclei. Bars,
10 mm (b) and 5 mm (c, d).
doi:10.1371/journal.pone.0005935.g001
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cytoskeletal and motor proteins. We found that tubulin, but not
actin, came down with SNX4 (Figure 1a). Furthermore, the minus
end-directed microtubule motor protein dynein was identified
(Figure 1a). This is in agreement with the recent finding that
SNX4 interacts with KIBRA, a dynein-interacting protein [10],
and suggests that SNX4 vesicle movement is mediated by dynein
on microtubuli. The co-immunoprecipitation of SNX4 with CHC,
tubulin and dynein was prevented in the presence of 100 nM
wortmannin (Figure 1a), indicating that the interactions require
membrane localization, most probably to the endosome [9]. As an
additional negative control, cells were transfected with siRNA
against SNX4, and the same experiment was performed. As
expected, when SNX4 was knocked down, less CHC was co-
immunoprecipitated with the remaining SNX4 (Figure 1a).
Effect of wortmannin and nocodazole on cellular
localization of CHC, tubulin and SNX4
Since SNX4 dissociates from endosomes upon wortmannin
treatment [9], and the interaction between SNX4 and CHC,
tubulin or dynein is lost at this condition (Figure 1a), we studied the
cellular localization of the mentioned proteins upon PI3-kinase
inhibition. In agreement with what was previously reported [20], we
observed a more clustered distribution of CHC in the presence of
wortmannin (not shown). Interestingly, a similar phenotype was
observed upon SNX4 knockdown (Figure 1b). As expected,
wortmannin did not affect the cellular distribution of tubulin
(Figure 1c).
We next studied the effect of nocodazole, a microtubule
depolymerising agent [21], on cellular protein localization.
Tubulin was severely affected by nocodazole treatment
(Figure 1d), as expected. At the same condition, less SNX4
staining could be observed (not shown). The latter could be due to
reduced endosome size, as nocodazole has been reported to
decrease the size of EEA1 positive vesicles [22]. However,
nocodazole also affected the cell morphology (Figure 1d), which
may lead to indirect effects on general protein localization.
GFP-SNX4 co-localizes with tubulin and CHC
Since the functional antibodies for use in immunofluorescence
experiments were all raised in mice, we could not perform co-
localization studies with endogenous SNX4 and its binding
partners. To circumvent this, we cloned and expressed SNX4 as
a GFP fusion protein. In agreement with the co-immunoprecip-
itation experiments, we observed GFP-SNX4 positive vesicles in
close proximity to, or overlapping with, tubulin (Figure 2a). In the
case of CHC, we observed a clear co-localization with GFP-
SNX4, and even triple co-localization with the early endosomal
protein EEA1 (Figure 2b). The fraction of GFP-SNX4 that co-
localized with CHC at moderate expression level was quantified to
be 27.866.6% (average with standard deviation, n=15), and with
tubulin 19.467.6% (average with standard deviation, n=5). In
order to exclude the possibility that this co-localization was
random, we expressed GFP alone and performed the correspond-
ing experiments. Even though GFP is expressed throughout the
cell, less than 0.5% co-localization could be detected with CHC
(n=16) or tubulin (n=10) (pictures not presented). This clearly
demonstrates that the co-localization between GFP-SNX4 and
CHC or tubulin is significant (p,0.0001 by Student’s t-test). At
high GFP-SNX4 expression level, CHC appeared more recruited
to GFP-SNX4 positive vesicles (Figure 2c). We furthermore
confirmed that endogenous SNX4 partly co-localized with
transiently expressed GFP-CLC (clathrin light chain)
(13.261.9%; average with standard deviation, n=10) (Figure
S1). These data support the suggestion of SNX4/tubulin and
SNX4/CHC complexes on endosomes.
SNX4 binds CHC via a clathrin box variant
A recognized CHC interacting motif is the so-called clathrin box
LWpW(2), where L is leucine, W a bulky hydrophobic residue, p a
polar residue, and (2) is a negatively charged residue [23]. Amino
acid sequenceanalysis of SNX4 did not show such a motif.However,
a variant, or an ‘‘inverted’’ clathrin box,
109EFELL, was found in its
PX domain. We therefore chose to test whether this sequence was
required for CHC binding. We constructed the deletion mutant
SNX4 109-113D and also designed a SNX4 construct deleted of its
C-terminal half, SNX4 198-451D (Figure 3a). Both wild-type SNX4
and the two mutants were designed with a myc-tag. Since a mutation
in the PX domain could potentially affect the endosomal localization
of SNX4, we first investigated the cellular distribution of the
recombinant SNX4 proteins by immunofluorescence. No apparent
change in localization was observed for SNX4 109-113D compared
to SNX4 wt (Figure S2a), but its co-localization with EEA1 was
reducedto67%relativetothewildtype(n=6forSNX4wtand8for
SNX4 109-113D) (Figure S2b). SNX4 198-451D was for an
unexplained reason present in the nucleus in addition to its expected
cytoplasmic localization (Figure S2a). We next performed anti-myc
immunoprecipitation experiments on cells expressing the SNX4
constructs, and examined the presence of CHC. As shown in
Figure 3b, a mild reduction in the CHC binding was observed for
SNX4 198-451D, whereas it was practically abolished for the SNX4
109-113D mutant. Three independent experiments were quantified
and corrected for SNX4 expression level. The result showed an
,80% reduction in CHC binding for SNX4 109-113D compared to
SNX4 wt (Figure 3b). This suggests that the clathrin box variant
present in SNX4 may be a CHC binding site. In order to validate
this, we designed GST-peptides from the SNX4sequence containing
the putative CHC binding motif. We made one peptide containing
amino acids 101–132, and a shorter one from amino acid 105–116
(Figure3c).Thepeptideswerepurifiedandaddedtocelllysatebefore
pull-down. CHC was present in both the 101–132 and 105–116 pull-
downs (Figure 3c). GST alone was used as negative control and was
unable to pull down CHC (Figure 3c). Sequences corresponding to
109EFELL in SNX4 are also present in other SNXs. We therefore
investigated whether these sequences from SNX1, SNX2 and SNX3
could also pull down CHC. A sequence containing the clathrin box
of Hrs was used as positive control [20]. The clathrin box of Hrs is
represented from the C- to the N-terminal end (rev) and aligned with
the putative clathrin boxes of the SNXs in Figure 3d. The main
residues are conserved. In pull-down experiments all the peptides,
but not GST alone, were able to bind CHC (Figure 3d). In order to
study the contribution of the different amino acids of
109EFELL, we
performed an ‘‘alanine scan’’ of the shortpeptide.We exchanged the
five amino acids one by one with alanine (Figure 3e), and performed
pull-down experiments with these peptides. We observed that the
E109A mutant was still able to pull down CHC, perhaps more
efficiently than the wild type, while the mutants F110A, E111A,
L112A and L113A only showed background binding to CHC
(Figure 3e). Interestingly, F110 and L113 are strictly conserved in all
the putative clathrin boxes tested (Figure 3d), and might represent
necessary residues. From these data we conclude that the SNX4
clathrin box variant is important for CHC binding.
The SNX4 interaction with dynein does not require CHC
To further investigate how SNX4 interacts with CHC and
dynein, we used CHC siRNA to reduce the level of CHC, and
then immunoprecipitated SNX4. If the SNX4/dynein interaction
is independent of CHC, dynein should be found in the precipitate
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PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e5935Figure 2. GFP-SNX4 co-localizes with tubulin and CHC. (a–b) Cells were transiently transfected with GFP-SNX4 for 24 h before the cells were
fixed and stained as indicated. (c) Cells expressing high levels of GFP-SNX4 were fixed and stained as indicated. DRAQ5 was used to stain the nuclei.
Bars, 5 mm.
doi:10.1371/journal.pone.0005935.g002
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the case. This opens for the possibility that SNX4 forms separate
complexes with CHC and dynein, an idea supported by the result
that dynein and CHC bind to the same area of SNX4 (see below).
We next investigated the effect of the microtubule depolymerising
agent nocodazole on complex formation. As shown in Figure 4b,
both CHC and dynein could still interact with SNX4 in cells
treated with nocodazole. Interestingly, an increased binding of
CHC to SNX4 was observed (2.30 fold60.99, average6standard
deviation, n=3) (Figure 4b).
In order to clarify whether dynein and CHC bind to the same
region of SNX4, we performed GST pull-down experiments with the
peptides GST-SNX4 101–132 and 105–116 and probed with anti-
dynein.Dyneinboundtobothpeptides(Figure4c),buttheinteraction
wassignificantlystrongerwiththe101–132peptide.Thissuggeststhat
additionalaminoacidspresentonlyinthelongpeptideareinvolvedin
dyneinbinding,orthattheadditionalaminoacidsgiveabetterfolding
of this peptide. In order to test this, we performed immunoprecip-
itation experiments with the SNX4 109-113D mutant. As shown in
Figure 4d, dynein could still interact with this mutant, indicating that
the clathrin box alone is not sufficient for dynein binding.
Knockdown of CHC causes increased retrograde
transport of ricin
Knockdown of SNX4 results in reduced endosome to Golgi
transport of the protein toxin ricin [9]. Ricin is after endocytosis
transported via early endosomes and the Golgi apparatus, to the
endoplasmic reticulum (ER). Since we here show that SNX4 and
CHC form a complex, we were interested in the effect of reduced
CHC levels on ricin transport. We took advantage of siRNA to
knock down CHC, and employed both the oligo-based and vector-
based approach (siCHCo and siCHCv, respectively). Figure 5a
shows the strong effect of these siRNAs on the protein level of
CHC. One can measure the amount of ricin reaching the Golgi by
studying the sulfation, a protein modification taking place only in
the trans-Golgi network, of a genetically engineered ricin molecule
containing a sulfation site [19]. Upon CHC knockdown, we
observed increased ricin sulfation (Figure 5b). This is in contrast to
what is seen with reduced SNX4 levels [9]. Importantly, several
independent reports have shown that ricin endocytosis remains
efficient in cells where clathrin-dependent endocytosis is perturbed
[24–27]. We also confirmed that ricin degradation was not
affected by CHC knockdown (not shown). In order to confirm the
increased retrograde transport in CHC knockdown cells, we
measured the mannosylation of ricin which takes place in the
endoplasmic reticulum. In agreement with the sulfation data, we
observed a strong increase in ricin mannosylation when CHC was
knocked down (Figure 5c, black bars). Total protein mannosyla-
tion was also mildly increased at this condition (Figure 5c, white
bars). We next studied the cellular localization of ricin by confocal
microscopy. Interestingly, ricin appeared in dense perinuclear
clusters in knockdown cells, in contrast to the spread vesicular
Figure 3. SNX4 interacts with CHC via a clathrin box variant. (a) Schematic view of SNX4 wt, SNX4 198-451D and SNX4 109-113D. (b) Cells
transfected as indicated were lysed and proceeded to anti-myc immunoprecipitation for 4 h at 4uC. The immunoprecipitate and whole cell lysate
(WCL) were separated by SDS-PAGE and analyzed by Western blot with the indicated antibodies. Quantification of CHC binding corrected for
expression level of the myc constructs is shown to the right, n=3. (c) The amino acid sequences of GST-peptides are shown with putative clathrin box
in red. The numbering represents amino acid number in the SNX4 sequence. GST pull-down was performed with cell lysate at 4uC overnight. The pull-
down was subjected to SDS-PAGE and analyzed by Western blot with the indicated antibodies. GST alone was used as negative control. (d) Putative
clathrin boxes of SNX1, SNX2, SNX3, SNX4 (105–116) and reverse clathrin box of Hrs are aligned. GST pull-down was performed as in (c) with the
indicated peptides. (e) Schematic view of GST-peptides containing the putative clathrin box (red) and point mutations (blue). GST pull-down was
performed as in (c) with the indicated peptides.
doi:10.1371/journal.pone.0005935.g003
SNX4 Binds Clathrin and Dynein
PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e5935localization in control cells (Figure 5d). Also SNX4 changed its
localization upon CHC knockdown (Figures 5d and S3).
Interestingly, it co-localized to a similar extent (,40%) with ricin
both in control and knockdown cells (Figure 5d), consistent with its
role in ricin transport [9]. In knockdown cells, some CHC could
still be detected close to the nucleus, and of this, 73.8614.0%
(average with standard deviation, n=7) co-localized with SNX4.
In agreement with the biochemical assays (Figure 5b, c), the ricin
cluster in knockdown cells co-localized with the trans-Golgi protein
TGN46 (Figure 5e). Quantification revealed a 2.4 fold increase in
ricin co-localization with TGN46 in CHC knockdown cells
compared to control cells, and a 22.6 fold increase in TGN46
structures positive for ricin (n=4 for control cells and 7 for siCHC
cells, p=0.025 and ,0.0001 by Student’s t-test for the two
measurements, respectively). The difference in these numbers is
likely due to the fact that TGN46 labelling remained stable upon
Figure 4. The SNX4 interaction with dynein does not require CHC. (a) Cells were transfected with control siRNA or siRNA targeting CHC
(siCHC) as described in Materials and Methods. Lysate of the cells was then subjected to SNX4 immunoprecipitation at 4uC overnight, and the
precipitate separated by SDS-PAGE before Western blot analysis with the indicated antibodies. (b) Cells were treated with or without nocodazole for
30 min before lysis and SNX4 immunoprecipitation. The precipitate was separated by SDS-PAGE and analysed by Western blot with the indicated
antibodies. (c) GST pull-down of 101–132, 105–116 or GST alone was performed with cell lysate at 4uC overnight. The pull-down was subjected to
SDS-PAGE and analyzed by Western blot with the indicated antibodies. (d) Cells transfected as indicated were lysed and proceeded to anti-myc
immunoprecipitation for 3 h at 4uC. The immunoprecipitate and whole cell lysate (WCL) were separated by SDS-PAGE and analyzed by Western blot
with the indicated antibodies.
doi:10.1371/journal.pone.0005935.g004
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knockdown cells due to its clustering (see Figure 5e). This will
influence the relative calculations. In summary, these data show
that ricin transport to the Golgi apparatus is enhanced upon CHC
knockdown. We also studied the effect of expressing the SNX4
109-113D mutant on ricin trafficking, but did not observe any
clear effect (data not shown).
Discussion
SNX4 binds to PI(3)P at the endosome, and is an effector of the
PI3-kinase hVps34 in endosome to Golgi transport of ricin [9].
Furthermore, the activity of hVps34 is required for minus-end
directed endosome motility [13], and SNX4 has recently been
reported to interact with KIBRA, which binds the minus-end
directed motor protein dynein [10]. In the present study, we
confirm that SNX4 and dynein are found in the same complex,
and show that SNX4 also binds CHC. However, the roles of
dynein and CHC in endosome motility are contrary. CHC
appears to serve as a negative regulator of vesicular movement.
This is supported by both biochemical and imaging data showing
that CHC knockdown leads to increased retrograde transport of
ricin.
An interaction between SNX4 and CHC has not previously
been reported. It is not clear why a proteomics study of clathrin
coated vesicles in HeLa cells identified several SNXs, but not
SNX4 [28]. The CHC interacting motif in SNX4 was in the
present study identified to be a short clathrin box resembling
sequence. This motif is part of an helical structure, a1, conserved
in PX-domain containing proteins [29]. The sequence similarity to
the PX domain in the crystallized p40
phox suggests that this helix is
exposed at the protein surface also in SNX4 [30]. Amino acids
directly upstream of the clathrin box resembling motif are involved
in PI(3)P binding [30]. When the sequence was deleted, SNX4 co-
localization with EEA1 was only slightly reduced, while binding to
CHC was strongly inhibited. However, it was not completely
abolished, indicating that another part of the protein may be
involved in CHC binding. The same has been observed for epsin 1
Figure 5. CHC knockdown leads to increased ricin transport. (a) Transfected cells were lysed and analyzed by Western blot with the indicated
antibodies. (b) Cells transfected as indicated were incubated with radioactive sulphate for 3 h before further incubation with ricin sulf-1 for 90 min
and subsequent lysis. Ricin was immunoprecipitated from the lysates, and the precipitate separated by SDS-PAGE before autoradiography. The
intensity of the bands was quantified and the average plotted with error bars showing standard deviations. (c) Transfected cells were incubated with
[
3H]mannose in glucose free medium for 3 h before further incubation with ricin sulf-2 for 3 h. Cell lysate was immunoprecipitated with anti-ricin
antibodies. The precipitate was analyzed by autoradiography. (d) Cells transfected as indicated were incubated with 2 mg/ml ricin for 45 min before
fixation and staining with antibodies as indicated. Bars, 5 mm. (e) Cells transfected with siCHCv were incubated with 2 mg/ml ricin for 45 min before
fixation and staining with the indicated antibodies. Asterisks in the merged picture indicate control cells. Bar, 5 mm.
doi:10.1371/journal.pone.0005935.g005
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expressing the SNX4 clathrin box in a short peptide, we showed
that it was sufficient to pull down CHC. Furthermore, individual
amino acids in the motif were crucial for the CHC binding.
Importantly, we cannot exclude that the mutation analysis
abrogates the helical structure of the domain. Interestingly, we
found that dynein interacted with the same region of SNX4 as
CHC, but the clathrin box variant was not sufficient for dynein
binding. For both CHC and dynein, the interaction was stronger
with the longest SNX4 peptide (101–132), probably because this
peptide contains the complete a1 helix [29]. PX domains of other
proteins have also been shown to be involved in protein-protein
interactions [29,32], and we found that the corresponding
sequences from SNX1, SNX2 and SNX3 also could bind CHC.
A variety of clathrin boxes has previously been identified [31,33],
and we propose that the CHC interacting sequence of SNX4
functions as a clathrin box.
The role of CHC in ricin retrograde transport has previously
been studied using a CHC antisense inducible cell line [34]. In this
cell line, transport of ricin from endosomes to the Golgi was not
affected [34]. An important difference between the antisense
system and the siRNA system used in the present study is that the
CHC protein level is reduced upon siRNA treatment. The
antisense cell line still has CHC, although not functional, present
at a high level [35]. Interestingly, a different requirement for CHC
is reported for endosome to Golgi transport of Shiga toxin [36,37].
Shiga toxin induces phosphorylation of CHC, which again
regulates toxin uptake [38]. It is possible that such CHC
phosphorylation is necessary for proper endosome to Golgi
transport of Shiga as well.
We suggest that dynein access SNX4 after CHC release. This is
in agreement with the findings that the dynein/SNX4 interaction
is independent of CHC, and that dynein and CHC bind to the
same region of SNX4. When cells were treated with nocodazole,
an increased binding of CHC to SNX4 was observed. This could
be a result of obstructed vesicle movement due to tubulin
depolymerisation, and therefore SNX4 remains bound to CHC.
Surprisingly, we did not observe an increased binding of dynein to
SNX4 upon CHC knockdown. This may be explained by an
altered kinetics in knockdown cells, since when CHC is reduced,
endosomes appear closer to the Golgi apparatus [39,40]. The
finding that CHC binding to SNX4 is increased while dynein
remains stable further indicates that CHC binding to SNX4 is
independent of dynein. However, one can not exclude that dynein
is present in excess and therefore sufficient for further recruitment
of CHC. By showing that SNX4 exists in complex with CHC,
most probably upstream of its interaction with dynein, we
contribute with another piece of the endosomal puzzle.
Supporting Information
Text S1
Found at: doi:10.1371/journal.pone.0005935.s001 (0.04 MB
DOC)
Figure S1 SNX4 co-localizes with GFP-CLC. Cells were
transfected with GFP-CLC for 24 h before fixation and staining
with anti-SNX4 antibodies. Bar, 10 mm.
Found at: doi:10.1371/journal.pone.0005935.s002 (3.59 MB TIF)
Figure S2 Cellular localization of SNX4 mutants (a) Cells
transfected with the indicated myc-tagged SNX4 constructs were
fixed and stained with anti-myc antibodies. DRAQ5 was used to
stain the nuclei. (b) Cells transfected with the indicated myc-tagged
SNX4 constructs were fixed and stained with anti-myc and anti-
EEA1 antibodies. Bars, 10 mm.
Found at: doi:10.1371/journal.pone.0005935.s003 (0.26 MB
PDF)
Figure S3 GFP-SNX4 alters its localization in CHC knockdown
cells. Cells transfected with a control vector or siCHCv for 72 h
were transfected with GFP-SNX4 for the last 24 h before fixation
and staining as indicated. DRAQ5 was used to stain the nuclei.
Bar, 5 mm.
Found at: doi:10.1371/journal.pone.0005935.s004 (0.18 MB
PDF)
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